Medical device maker Medtronic is looking at options to modify its global manufacturing footprint as part of efforts to ...

The U.S. Food and Drug Administration has approved Medtronic's deep brain stimulation system for use in patients with ...

Medtronic (MDT) is reportedly looking at adjusting its global manufacturing footprint amid heightened concerns that the U.S.

After decades of development and trials, Medtronic has secured U.S. Food and Drug Administration approval for adaptive ...

Medtronic, a leader in medical technology and Philips, a leader in health technology announced the signing of a Memorandum of ...

We recently published a list of Dividend Stock Portfolio For Income: Top 10 Stocks to Buy. In this article, we are going to ...

Medtronic (NYSE: MDT) announced that investigators enrolled the first patient in a pivotal trial of its Prevail drug-coated ...

ViCentra announced today that it appointed Tom Arnold as its new CEO to accelerate growth with the Kaleido automated insulin ...

The biggest technical challenge for adaptive deep brain stimulation (aDBS) is how small brain signals are, Medtronic's Scott ...

The FDA approved Medtronic's BrainSense Adaptive DBS and Electrode Identifier for Parkinson's, enhancing therapy ...

(NYSE: MDT) announced today that the FDA approved its BrainSense adaptive deep brain stimulation (aDBS) platform.

The company's adaptive deep brain stimulation technology for Parkinson's disease therapy is expected to be available ...